Production of Inflammatory Mediators in Conditioned Medium of Adipose Tissue-Derived Mesenchymal Stem Cells (ATMSC)-Treated Fresh Frozen Plasma.

IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Medical Science Monitor Basic Research Pub Date : 2022-03-23 DOI:10.12659/MSMBR.933726
Dian Ratih Laksmitawati, Wahyu Widowati, Rachmawati Noverina, Wireni Ayuningtyas, Dedy Kurniawan, Hanna Sari Widya Kusuma, Ervi Afifah, Ratih Rinendyaputri, Rilianawati Rilianawati, Ahmad Faried, Ni Ketut Susilarini
{"title":"Production of Inflammatory Mediators in Conditioned Medium of Adipose Tissue-Derived Mesenchymal Stem Cells (ATMSC)-Treated Fresh Frozen Plasma.","authors":"Dian Ratih Laksmitawati,&nbsp;Wahyu Widowati,&nbsp;Rachmawati Noverina,&nbsp;Wireni Ayuningtyas,&nbsp;Dedy Kurniawan,&nbsp;Hanna Sari Widya Kusuma,&nbsp;Ervi Afifah,&nbsp;Ratih Rinendyaputri,&nbsp;Rilianawati Rilianawati,&nbsp;Ahmad Faried,&nbsp;Ni Ketut Susilarini","doi":"10.12659/MSMBR.933726","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND Inflammation is the body's first response to an illness that causes irritation or infection. Inflammation is tightly correlated with aging, which is a progressive degenerative process. Conditioned medium (CM) from adipose tissue-derived mesenchymal stem cells (CM-ATMSCs) has been shown to stimulate collagen synthesis and dermal fibroblast migration, as well as reduce wrinkles and improve wound healing. This study aimed to observe the production of inflammatory modulators - interleukin (IL)-1alpha, IL-6, IL-10, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) - in CM-ATMSCs treated with fresh frozen plasma (FFP) at passages 3 (P3), 7, 11, and 15. MATERIAL AND METHODS ATMSCs P3 were obtained from liposuction of female donors, and the CM from ATMSCs was collected. Measurement of these cytokines was performed with ELISA. RESULTS At many passages, IL-6, a proinflammatory modulator, was discovered to be the most powerful modulator among FFP- and non-FFP-treated cells. However, CM-ATMSCs treated with FFP and in the late passage have significant differences (P<0.05) compared to non-FFP treatments and in other passages in their effects on secretion of inflammatory modulators. CONCLUSIONS In conclusion, CM-ATMSC has the potential to secrete proinflammatory modulators.</p>","PeriodicalId":18491,"journal":{"name":"Medical Science Monitor Basic Research","volume":" ","pages":"e933726"},"PeriodicalIF":2.0000,"publicationDate":"2022-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/82/medscimonitbasicres-28-e933726.PMC8958862.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor Basic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12659/MSMBR.933726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 2

Abstract

BACKGROUND Inflammation is the body's first response to an illness that causes irritation or infection. Inflammation is tightly correlated with aging, which is a progressive degenerative process. Conditioned medium (CM) from adipose tissue-derived mesenchymal stem cells (CM-ATMSCs) has been shown to stimulate collagen synthesis and dermal fibroblast migration, as well as reduce wrinkles and improve wound healing. This study aimed to observe the production of inflammatory modulators - interleukin (IL)-1alpha, IL-6, IL-10, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) - in CM-ATMSCs treated with fresh frozen plasma (FFP) at passages 3 (P3), 7, 11, and 15. MATERIAL AND METHODS ATMSCs P3 were obtained from liposuction of female donors, and the CM from ATMSCs was collected. Measurement of these cytokines was performed with ELISA. RESULTS At many passages, IL-6, a proinflammatory modulator, was discovered to be the most powerful modulator among FFP- and non-FFP-treated cells. However, CM-ATMSCs treated with FFP and in the late passage have significant differences (P<0.05) compared to non-FFP treatments and in other passages in their effects on secretion of inflammatory modulators. CONCLUSIONS In conclusion, CM-ATMSC has the potential to secrete proinflammatory modulators.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脂肪组织源性间充质干细胞(ATMSC)处理的新鲜冷冻血浆条件培养基中炎症介质的产生。
炎症是人体对引起刺激或感染的疾病的第一反应。炎症与衰老密切相关,衰老是一个渐进的退行性过程。来自脂肪组织来源的间充质干细胞(CM- atmscs)的条件培养基(CM)已被证明可以刺激胶原合成和真皮成纤维细胞迁移,以及减少皱纹和促进伤口愈合。本研究旨在观察用新鲜冷冻血浆(FFP)处理的CM-ATMSCs在第3代(P3)、7、11和15代时炎症调节剂-白细胞介素(IL)-1 α、IL-6、IL-10和活化B细胞核因子-轻链增强子(NF-kappaB)的产生。材料与方法女性供体抽脂获得ATMSCs P3,收集ATMSCs CM。用ELISA法测定这些细胞因子。结果在多次传代中,IL-6(一种促炎调节剂)被发现是FFP处理和非FFP处理细胞中最有效的调节剂。然而,经FFP处理的CM-ATMSCs和传代后期的CM-ATMSCs有显著差异(P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Science Monitor Basic Research
Medical Science Monitor Basic Research MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
6.00
自引率
0.00%
发文量
16
期刊最新文献
Therapeutic Mechanisms of Jinshuiqing in IgA Nephropathy: A Transcriptomic Analysis. Efficacy of Different Concentrations of Melatonin on Cultured Human Periodontal Ligament Stem Cells. Enhanced Tumor Targeting with Midazolam-Loaded PLGA Nanoparticles: An In Vivo Analysis of Safety and Efficacy. Adult Intussusception in Jordan: Demographics, Clinical Features, and Outcomes from a Tertiary Hospital. Correlation of Cytokine Profiles with Prostate-Specific Antigen and Disease Grade in Prostate Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1